STRO

Sutro Biopharma (STRO)

Sutro Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:STRO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	06:00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05:34	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/05/14	05:30	GlobeNewswire Inc.	Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones	NASDAQ:STRO	Sutro Biopharma Inc
2024/04/30	21:00	GlobeNewswire Inc.	Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial	NASDAQ:STRO	Sutro Biopharma Inc
2024/04/02	19:18	GlobeNewswire Inc.	Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/26	05:30	GlobeNewswire Inc.	Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/08	06:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/06	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/06	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/03/05	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/28	06:33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/14	02:16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/12	20:06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/10	06:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/10	06:25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/07	06:05	GlobeNewswire Inc.	Sutro Biopharma to Participate in Upcoming Investor Conferences	NASDAQ:STRO	Sutro Biopharma Inc
2024/02/01	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/30	07:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/08	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2024/01/05	06:05	GlobeNewswire Inc.	Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC	NASDAQ:STRO	Sutro Biopharma Inc
2023/12/15	06:05	GlobeNewswire Inc.	Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024	NASDAQ:STRO	Sutro Biopharma Inc
2023/12/12	06:05	GlobeNewswire Inc.	Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (luvelta) in Pediatric Patients with Relapsed/Refractory CBF/GLIS Presented at ASH 2023	NASDAQ:STRO	Sutro Biopharma Inc
2023/12/05	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STRO	Sutro Biopharma Inc
2023/12/05	06:05	GlobeNewswire Inc.	Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:STRO	Sutro Biopharma Inc
2023/11/28	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STRO	Sutro Biopharma Inc
2023/11/28	06:00	GlobeNewswire Inc.	Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates	NASDAQ:STRO	Sutro Biopharma Inc